Research

Pharmaceutical Sciences

Title :

In silico discovery and biological evaluation of potential drug molecules to improve the treatment of Bedaquiline and Delamanid resistance in Mycobacterium tuberculosis.

Area of research :

Pharmaceutical Sciences

Focus area :

Drug Discovery and Microbiology

Principal Investigator :

Dr. Shalini Saxena, University of Hyderabad, Telangana (500046)

Timeline Start Year :

2024

Timeline End Year :

2027

Contact info :

Details

Total Budget (INR):

36,14,100

Organizations involved